Dr. Neiwete Lomi

 

Dr. Neiwete Lomi is currently Associate Professor at Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi. Dr. Lomi has done MBBS from SKMCH, Muzaffarpur, Bihar and completed post-graduation in Ophthalmology from AIIMS, New Delhi. Subsequently, he obtained super specialty training in Cornea, Refractive Surgery and Glaucoma from PGIMER Chandigarh. His current field of interest is in ocular oncology, specially retinoblastoma and uveal melanoma. Besides ocular oncology works, he is also a compassionate and dedicated ophthalmic surgeon working actively in clinical and research activity in the speciality of cornea, cataract and refractive surgery.  Dr. Lomi is one of the first ophthalmic surgeon from north India to perform plaque brachytherapy on ocular tumors since 2017 and also initiated Gamma knife stereotactic radiosurgery for treating large choroidal melanoma in collaboration with Gamma knife unit at AIIMS. Currently he is working in institutional project on melanogenesis in ocular melanoma, Radiomics and Radiogenomics profiling in retinoblastoma and improvised plaque brachytherapy for various ocular tumours.

OPDs: Room no. 33. Wed/Sat 9am-1pm.

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

RECENT PUBLICATIONS  

 

1. Shubha G R, Aditi Khurana, Sumit Garg, Rachna Seth, Neiwete Lomi, Chetan Patel, Rakesh Kumar. Comparison between the diagnostic accuracy of F-18 FDG PET/CT scan and Tc-99m MDP bone scintigraphy for detection of distant metastasis in extra-ocular retinoblastoma- a single centre initial experience. Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2785.
2. Lata Singh, Mithalesh Kumar Singh, Moshahid Alam Rizvi, Sameer Bakhshi, Rachna Meel, Neiwete Lomi, Seema Sen, Seema Kashyap. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunology, Immunotherapy.  2020 Feb 26. doi: 10.1007/s00262-020-02529-4.
3. Kashyap Seema, Singh Lata, Kumar Nikhil, Singh Mithalesh, Pushker Neelam, Bakshi Sameer, Sen Seema, Lomi Neiwete, Meel Rachna, Chawla Bhavna . Combined association of Massive choroidal and Optic nerve invasion as a prognostic relevance in Primary Retinoblastoma: A 10 year study. Asia-PacJClinOncol.2020;1–9.
4. Seema Kashyap, Mithelesh Kumar Singh, Jayanti Jha, Lata Singh, Neelam Pushker, Seema Sen, Pradeep Venketesh, Rachna Meel, Neiwete Lomi. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma. Human Cell. Doi.org/10.1007/s13577-020-00397-9.
5. Lata Singh, Mithalesh Kumar Singh, Maria Cristina Kenney, Martine J. Jager, Moshahid Alam Rizvi, Rachna Meel, Neiwete Lomi, Sameer Bakhshi, Seema Sen, Seema Kashyap. Prognostic significance of PD‐1/PD‐L1 expression in uveal melanoma: correlation with tumor‐infiltrating lymphocytes and clinicopathological parameters. Cancer Immunology, Immunotherapy https://doi.org/10.1007/s00262-020-02773-8.